BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hou H, Kang Y, Zeng Y, Li Y, Shang J. Interleukin-7 augments CD8+ T cells function and promotes viral clearance in chronic hepatitis C virus infection. Cytokine 2018;102:26-33. [PMID: 29275010 DOI: 10.1016/j.cyto.2017.12.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Huang J, Long Z, Jia R, Wang M, Zhu D, Liu M, Chen S, Zhao X, Yang Q, Wu Y, Zhang S, Tian B, Mao S, Ou X, Sun D, Gao Q, Cheng A. The Broad Immunomodulatory Effects of IL-7 and Its Application In Vaccines. Front Immunol 2021;12:680442. [PMID: 34956167 DOI: 10.3389/fimmu.2021.680442] [Reference Citation Analysis]
2 Tian X, Su Z, Guo S, Wang C, Zhang X, Du J. Interleukin-7 promotes CD8+ T cell activity in patients with enterovirus 71 associated encephalitis. International Immunopharmacology 2019;75:105773. [DOI: 10.1016/j.intimp.2019.105773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Herold KC, Bucktrout SL, Wang X, Bode BW, Gitelman SE, Gottlieb PA, Hughes J, Joh T, McGill JB, Pettus JH, Potluri S, Schatz D, Shannon M, Udata C, Wong G, Levisetti M, Ganguly BJ, Garzone PD; RN168 Working Group. Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes. JCI Insight 2019;4:126054. [PMID: 31852846 DOI: 10.1172/jci.insight.126054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
4 Lee SW, Choi D, Heo M, Shin EC, Park SH, Kim SJ, Oh YK, Lee BH, Yang SH, Sung YC, Lee H. hIL-7-hyFc, A Long-Acting IL-7, Increased Absolute Lymphocyte Count in Healthy Subjects. Clin Transl Sci 2020;13:1161-9. [PMID: 32339447 DOI: 10.1111/cts.12800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Li S, Wang Z, Zhang G, Fu J, Zhang X. Interleukin-7 promotes lung-resident CD14+ monocytes activity in patients with lung squamous carcinoma. International Immunopharmacology 2019;67:202-10. [DOI: 10.1016/j.intimp.2018.12.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Teng D, Ding L, Cai B, Luo Q, Wang H. Interleukin-7 enhances anti-tumor activity of CD8+ T cells in patients with hepatocellular carcinoma. Cytokine 2019;118:115-23. [DOI: 10.1016/j.cyto.2018.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Chen C, Zhou M, Yan X, Chen Y, Cui M, Chen H, Fu Z, Zhao L. A recombinant canine distemper virus expressing interleukin-7 enhances humoral immunity. Journal of General Virology 2019;100:602-15. [DOI: 10.1099/jgv.0.001247] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
8 Zhang ZH, Wang H, Zhang DN, Zhu GZ. Notch signaling suppresses CD14+ monocytes cells activity in patients with chronic hepatitis C. APMIS 2019;127:642-52. [PMID: 31274210 DOI: 10.1111/apm.12980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]